You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Autologous Hematopoietic Stem Cell Transplant

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in New York (Ide-cel (bb2121))

Recruiting
  • Multiple Myeloma
  • Ide-cel (bb2121)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 6, 2022

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Hematologic Malignancy Trial in Boston (PATH-C)

Not yet recruiting
  • Hematologic Malignancy
  • PATH-C
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Nov 23, 2023

Multiple Myeloma, Myeloma-Associated Amyloidosis Trial in Saint Louis (Selinexor, Lenalidomide, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Myeloma-Associated Amyloidosis
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 6, 2023

Hematopoietic Tumors, Hematopoietic Malignancy Trial in Boston (STEPP Intervention, Usual Care)

Not yet recruiting
  • Hematopoietic Neoplasms
  • Hematopoietic Malignancy
  • STEPP Intervention
  • Usual Care
  • Boston, Massachusetts
  • +1 more
Aug 30, 2023

Multiple Myeloma Trial in Tampa (biological, procedure, drug)

Active, not recruiting
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022

Vaccination, Hematopoietic Stem Cells Trial in Lyon, Pierre-Bénite (immune biomarkers to evaluate vaccine response in HSCT

Active, not recruiting
  • Vaccination
  • Hematopoietic Stem Cells
  • immune biomarkers to evaluate vaccine response in HSCT recipients
  • Lyon, France
  • +1 more
Jun 15, 2022

B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 6, 2021

Myeloma Trial in Philadelphia (Belantamab mafodotin)

Recruiting
  • Myeloma
  • Belantamab mafodotin
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Jun 13, 2022

Blood Disease Trial (TCRaß+/CD19+ depleted Hematopoietic stem cell (HSC) graft, CliniMACS® System)

Not yet recruiting
  • Blood Disease
  • TCRαβ+/CD19+ depleted Hematopoietic stem cell (HSC) graft
  • CliniMACS® System
  • (no location specified)
Jan 30, 2023

Lymphoma, Non-Hodgkin Trial in Saint Louis (Stem cell infusion, TLI, Anti-thymocyte globulin)

Active, not recruiting
  • Lymphoma, Non-Hodgkin
  • Stem cell infusion
  • +5 more
  • Saint Louis, Missouri
    Washington University
Jan 17, 2023

Multiple Myeloma Trial in Cleveland (Evomela, Next Generation Sequencing, Prochlorperazine)

Not yet recruiting
  • Multiple Myeloma
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Apr 19, 2022

Cytomegalovirus Infection Trial (Letermovir)

Not yet recruiting
  • Cytomegalovirus Infection
  • (no location specified)
Feb 28, 2023

Ontogeny of MAIT Cells in Neonates and Hematopoietic Stem Cell

Completed
  • Term and Preterm Neonates (24-41 Weeks Gestational Age)
  • Hematopoietic Stem Cell Transplant Recipient Children
  • Tubes fund recovery blood count
  • the rest of the blood test and stool sample
  • Paris, France
    Hôpital Robert Debré
Feb 2, 2023

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
Has Results
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

Multiple Myeloma Trial (Iberdomide, Daratumumab/rHuPH20 Co-formulation)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Oct 25, 2023

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Tumor, Caregivers Trial run by the National Institutes of Health Clinical Center (CC) (Sham VR, Active VR)

Not yet recruiting
  • Neoplasm
  • Caregivers
  • Sham VR
  • Active VR
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 26, 2023

Complications After Hematopoietic Stem Cell Transplant

Recruiting
  • Hematopoietic and Lymphoid System Neoplasm
  • Malignant Solid Neoplasm
  • Clinical Evaluation
  • Electronic Health Record Review
  • Jacksonville, Florida
  • +1 more
Mar 2, 2023

Thalassemia Major Trial in Shanghai (?-globin reactivated autologous hematopoietic stem cells)

Not yet recruiting
  • Thalassemia Major
  • γ-globin reactivated autologous hematopoietic stem cells
  • Shanghai, Shanghai, China
    Shanghai Bioray Laboratories Inc
Jul 1, 2022

ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

Recruiting
  • β-thalassemia
  • β-globin restored autologous hematopoietic stem cells
  • Shenzhen, Guangdong, China
    Shenzhen Children's Hospital
Feb 24, 2023

Acute Myeloid Leukemia, Minimal Residual Disease Negativity Trial in Seattle (procedure, drug, other)

Withdrawn
  • Acute Myeloid Leukemia
  • Minimal Residual Disease Negativity
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 27, 2021

Other Cancer Trial in Boston (Mobile App + enhanced standard care, Enhanced Standard Care)

Active, not recruiting
  • Other Cancer
  • Mobile App + enhanced standard care
  • Enhanced Standard Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Fluoroquinolone Resistance Prevalence Study

Recruiting
  • Multiple Myeloma
    • Washington, District of Columbia
    • +1 more
    Apr 10, 2023